Ann: PRIZMA Sponsorship with Royal Australian College of GPs, page-76

Hi kenjikool & @Poorrundownhill:

Let's just say "it's all over Red Rover" and get on with the job. Let's just agree to disagree on the CR.

The CR was and still is a necessary component to get GMV up and running. With one fowl swoop we cleared the books and set the company up for what should be a profitable future. This company would have to be one of tightest if not the tightest run company I have been involved in.

People would argue that it is top heavy and is setting up a bad precedent with the CEO having a controlling interest when it comes to decision making. I will personally come out on a limb and declare that Dr Yacov is the real deal (although a tad different) and he is 100% behind this company. Name any company CEO currently on the ASX who have invested so much of their own personal wealth on buy backs and personal loans.

The reason why Dr G owns so many shares, is because he was removed from his position of CEO at Lifewatch because he didn't have enough shares. BTW Lifewatch was taken over by Bio Telemetry (BEAT) a direct company in the Mobile Cardiac Telemetry EHealth field. Dr Yacov holds just over/under 50% of the Shares on Issue (SOI) with 92% of SOI owned controlled by no more then 250 SH's. So as I said before, GMV is very tightly held by not more than 250 SH's.

What prompted me to write this post was the number of shares sold in the past 13 days:
a. 1 May - 4,643 mil
b. 4 May - 3,154 mil
c. 5 May - 4,435 mil
d. 6 May - 2,915 mil.
e. 7 May - 9,880 mil
f. 8 May - 15,589 mil
g. 11 May - 7,399 mil
h. 12 May - 7,178 mil
i. 13 May - 10,474 mil

TOTAL - 65,667 mil.

Quite alot of shares from the CR have hit the decks, so hopefully that should do for awhile, although currently the Dow Jones is down some 500 points, so this morning we may experience some more aggressive selling. We really want the buy button heading Nth to come along.